PREVALENCE OF FATTY PANCREAS AMONG PATIENTS WITH NON-ALCOHOLIC FATTY LIVER DISEASE IN SULAIMANI
DOI:
https://doi.org/10.17656/jsmc.10094Keywords:
Fatty pancreas, Fatty liver, ObesityAbstract
Background
Fatty pancreas results from excessive ectopic fat accumulation represents a global health problem recently.
Objectives
To determine the prevalence of fatty pancreas among non alcoholic fatty liver patients and to find out the main risk factors for fatty pancreas.
Patients and Methods
A descriptive prospective observational study conducted at Kurdistan Center for Gastroenterology and Hepatology (KCGH) in Sulaimani governorate through the period from 1st April, 2014 to 31st of April, 2015 on convenient sample of 75 non-alcoholic fatty liver patients. The data was collected by researcher through direct interview and filling of questionnaire included demographic data, weight, height, smoking, drug history, laboratory results of Gamma-Glutamyl transferase (GGT) and lipid profile and ultrasound results of pancreas.
Results
The prevalence of fatty pancreas among patients with non alcoholic fatty liver diseases was 49.3%. Fatty pancreas was significantly predominant among elderly patients (p=0.03). Significant higher levels of triglycerides (p=0.03) and GGT (p=0.02) were found among fatty pancreas patients. High density lipoproteins level was significantly lower among fatty pancreas patients (p=0.04).
Conclusion
About half of patients with non alcoholic fatty liver diseases had non alcoholic fatty pancreas;The main risk factors for fatty pancreas were elderly age, male gender, obesity and abnormal lipid profile.
References
Finucane MM, Stevens GA, Cowan MJ, Danaei G, Lin JK, Singh GM, et al. National, regional, and global trends in body-mass index since 1980: systematic analysis of health examination surveys and epidemiological studies with 960 country-years and 9.1 million participants. Lancet 2011; 377: 557–67. DOI: https://doi.org/10.1016/S0140-6736(10)62037-5
Ou H-Y, Wang C-Y, Yang Y-C, Chen M-F, Chang C-J. The Association between Nonalcoholic Fatty Pancreas Disease and Diabetes. Sookoian SC, ed. PLoS ONE. 2013; 8(5):e62561. DOI: https://doi.org/10.1371/journal.pone.0062561
Mathur A, Marine M, Lu D, Swartz-Basile DA, Saxena R, Zyromski NJ, et al. Nonalcoholic fatty pancreas disease. HPB (Oxford) 2007; 9:312–18. DOI: https://doi.org/10.1080/13651820701504157
Prachayakul V, Aswakul P. Pancreatic Steatosis: What Should Gastroenterologists Know? JOP. J Pancreas (Online) 2015; 16(3):227-31.
Kotronen A, Westerbacka J, Bergholm R, Pietilainen KH, Yki-Jarvinen H. Liver Fat in the Metabolic Syndrome. J ClinEndocrinolMetab 2007; 92: 3490–97. DOI: https://doi.org/10.1210/jc.2007-0482
Targher G, Bertolini L, Poli F, Rodella S, Scala L, Tessari R, et al. Nonalcoholic fatty liver disease and risk of future cardiovascular events among type 2 diabetic patients. Diabetes 2005; 54: 3541–46. DOI: https://doi.org/10.2337/diabetes.54.12.3541
Lee JS, Kim SH, Jun DW, Han JH, Jang EC, Park JY, et al. Clinical implications of fatty pancreas: correlations between fatty pancreas and metabolic syndrome. World J Gastroenterol 2009; 15:1869–75. DOI: https://doi.org/10.3748/wjg.15.1869
Wu WC, Wang CY. Association between non-alcoholic fatty pancreatic disease (NAFPD) and the metabolic syndrome: case–control retrospective study. CardiovascDiabetol. 2013; 12:77. DOI: https://doi.org/10.1186/1475-2840-12-77
Sijens PE, Edens MA, Bakker SJ, Stolk RP. MRI determined fat content of human liver, pancreas and kidney. World J Gastroenterol. 2010; 16(16):1993-98. DOI: https://doi.org/10.3748/wjg.v16.i16.1993
Smits M, van Geenen E. The clinical significance of pancreatic steatosis. Nat Rev GastroenterolHepatol 2011; 8: 169-77. DOI: https://doi.org/10.1038/nrgastro.2011.4
Pitt H. Hepato-pancreato-biliary fat: the good, the bad and the ugly. HPB (Oxford) 2007; 9: 92-97. DOI: https://doi.org/10.1080/13651820701286177
Lesmana CRA, Pakasi LS, Inggriani S, Aidawati ML, Lesmana LA. Prevalence of Non-Alcoholic Fatty Pancreas Disease (NAFPD) and its risk factors among adult medical check-up patients in a private hospital: a large cross sectional study. BMC Gastroenterology2015; 15:174. DOI: https://doi.org/10.1186/s12876-015-0404-1
Powis ME, Chang KJ. Endoscopic ultrasound in the clinical staging and management of pancreatic cancer: Its impact on cost of treatment. Cancer Control 2000; 7(5):413–20. DOI: https://doi.org/10.1177/107327480000700503
Sandrasegaran K, Lin C, Akisik FM, Tann M. State of the art pancreatic MRI. Am J Rad 2010; 195:42–53. DOI: https://doi.org/10.2214/AJR.10.4421
World Health Organization. Physical status: The use and interpretation of anthropometry: Report of a WHO Expert committee. Technical report series 854, Geneva 1995.
Carter R, Mouralidarane A, Soeda J, Ray S, Pombo J, Sarawati R, et al. Non-Alcoholic Fatty Pancreas Disease Pathogenesis: A Role for Developmental Programming and Altered Circadian Rhythms. Targher G, ed. PLoS ONE. 2014; 9(3):e89505. DOI: https://doi.org/10.1371/journal.pone.0089505
Uygun A, Kadayifci A. The effect of fatty pancreas on serum glucose parameters in patients with nonalcoholic steatohepatitis. European Journal of Internal Medicine 2015; 26: 37–41. DOI: https://doi.org/10.1016/j.ejim.2014.11.007
Wang C, Ou H, Chen M, Chang T, Chang C. Enigmatic Ectopic Fat: Prevalence of Nonalcoholic Fatty Pancreas Disease and Its Associated Factors in a Chinese Population. Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease 2014; 3(1):e000297. DOI: https://doi.org/10.1161/JAHA.113.000297
Al Haddad M, Khashab M, Zyromski N, Pungapong S, Wallace MB, Scolapio J, et al. Risk factors for hyperechogenic pancreas on endoscopic ultrasound: a case control study. Pancreas 2009; 38: 672–5. DOI: https://doi.org/10.1097/MPA.0b013e3181a9d5af
Sepe PS, Ohri A, Sanaka S, Berzin TM, Sekhon S, Bennett G, et al. A prospective evaluation of fatty pancreas by using EUS. GastrointestEndosc 2011; 73:987–93. DOI: https://doi.org/10.1016/j.gie.2011.01.015
Pinnick KE, Collins SC, Londos C, Gauguier D, Clark A, Fielding BA. Pancreatic ectopic fat is characterized by adipocyte infiltration and altered lipid composition. Obesity (Silver Spring) 2008; 16:522–30. DOI: https://doi.org/10.1038/oby.2007.110
Patel NS, Peterson MR, Lin GY, Feldstein A, Schnabl B, Bettencourt R, et al. Insulin Resistance Increases MRI-Estimated Pancreatic Fat in Nonalcoholic Fatty Liver Disease and Normal Controls. Gastroenterology Research and Practice 2013; ID 498296, 8 pages. DOI: https://doi.org/10.1155/2013/498296
Hori M, Takahashi M, Hiraoka N, Yamaji T, Mutoh M, Ishigamori R, et al. Association of Pancreatic Fatty Infiltration with Pancreatic Ductal Adenocarcinoma. Clinical and Translational Gastroenterology. 2014; 5(3):e53. DOI: https://doi.org/10.1038/ctg.2014.5
Choi CW, Kim GH, Kang DH, Kim HW, Kim DU, Heo J, et al. Associated factors for a hyperechogenic pancreas on endoscopic ultrasound. World Journal of Gastroenterology : WJG 2010; 16(34):4329-34. DOI: https://doi.org/10.3748/wjg.v16.i34.4329
Downloads
Published
Issue
Section
License
Copyright (c) 2016 Kawa Abdullah Mahmood
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
This work is licensed under 